571-22-2

571-22-2 structure
571-22-2 structure

Name (5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
Synonyms 5beta,17beta-Hydroxyandrostan-3-one
5beta-Androstan-17beta-ol-3-one
Etiocholan-17beta-ol-3-one
5beta-Dihydrotestosterone
17beta-Hydroxyetiocholan-3-one
Density 1.085g/cm3
Boiling Point 413.1ºC at 760 mmHg
Molecular Formula C19H30O2
Molecular Weight 290.44000
Flash Point 176.4ºC
Exact Mass 290.22500
PSA 37.30000
LogP 3.95910
Index of Refraction 1.536

CHEMICAL IDENTIFICATION

RTECS NUMBER :
BV8054000
CHEMICAL NAME :
5-beta-Androstan-3-one, 17-beta-hydroxy-
CAS REGISTRY NUMBER :
571-22-2
LAST UPDATED :
199206
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C19-H30-O2
MOLECULAR WEIGHT :
290.49
WISWESSER LINE NOTATION :
L E5 B666 OVTJ A1 E1 FQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
240 mg/kg/5D-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
160 mg/kg
SEX/DURATION :
female 12-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - skin and skin appendages Reproductive - Effects on Newborn - delayed effects

MUTATION DATA

TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Human Lymphocyte
DOSE/DURATION :
50 umol/L
REFERENCE :
PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974
Risk Phrases 45-46-61-20/21/22
RTECS BV8054000
Precursor  0

DownStream  2